Form D · Private Equity Fund

Symbiotic Capital EB Parallel Fund, L.P.

Los Angeles, CA · CIK 0002013515

Offering snapshot reported Mar 11, 2025 · SEC filing

Reported sold: Yet to sell
Investors reported: 0
Minimum accepted: $0
First sale: Yet to occur

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Mar 11, 2025	Amendment	Yet to sell	No comparison	0	SEC filing
Mar 6, 2024	Initial	Yet to sell	No comparison	0	SEC filing

Offering details

Securities: Equity, Pooled investment fund
Exemptions: 06b, 3C, 3C.1, 3C.7
Duration over one year: Yes
Business combination: No

Sales commissions: $0
Finders' fees: $0
Form D file number: 021-506798

Source: Form D, filed Mar 11, 2025. Minimum accepted may differ from a standard advertised minimum.

Fund connections

The linked fund shows its most recently reported ADV details.

Matched by reported Form D file number

SYMBIOTIC CAPITAL EB PARALLEL FUND, L.P.

Investment adviser: SYMBIOTIC CAPITAL MANAGEMENT CO. LLC

Gross asset value: $8.81M
Beneficial owners: 2
ADV minimum commitment: $10M

Reported in Form ADV on Mar 31, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Fund administrator ALTER DOMUS (US) LLC CHICAGO, Illinois, United States Investor statements: Yes (provided to all investors) Related to adviser: No

Auditor ERNST & YOUNG LLP LOS ANGELES, California, United States

Custodian CITIBANK, NA NEW YORK, New York, United States Related to adviser: No

Marketer ARTIST CAPITAL LLC NEW YORK, New York, United States Related to adviser: No

Provider details

Annual audit: Yes
Prime brokers: No
Custodians: Yes
Administrator other than the adviser: Yes
External marketing: Yes

ERNST & YOUNG LLP
PCAOB 42

CITIBANK, NA
LEI E57ODZWZ7FF32TWEFA76

ARTIST CAPITAL LLC
CRD 153937 · SEC 8-68598

Filing source

Form ADV 2079137 · Mar 31, 2026 · Schedule D 7.B.(1), fund 805-9447431713

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Benjamin Belldegrun	Director
Arie Belldegrun	Director
Himani Bhalla	Director
Joshua Bradley	Director
Russell Goldsmith	Director
Franz Humer	Director
Joshua Kazam	Director
Symbiotic Capital Life Science Credit Fund Gp, L.P	Promoter

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:

Symbiotic Capital 10100 Santa Monica Blvd., Floor 15
Los Angeles, CA, 90067